ArticleJournal of cancer research and clinical oncology2023

Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study.

Daniel Roessler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.